Follow The Filings

CELC Celcuity Inc.

Health Care, filed as CELCUITY INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 3 managers in 2026 Q2

  • 2 exits

In 2026 Q2 Polen Capital Management and Farallon Capital Management sold out of Celcuity.

Who owns CELC

Sorted by value, long equity only, as of 2026 Q2.

History
Polen Capital Management exited 2026 Q2 Last 2026 Q1 0.01% Exit −0.01% 17,181 $2M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 4,000 $457K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CELC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CELC insider trades
  • None no insider bought on the open market
  • $319M sold by 2 insiders outside a trading plan
  • $9M sold by 2 insiders under 10b5-1 plans
  1. Baker Bros. Advisors LP Insider, +3 joint filers
    Sale
    $318M 3,100,000 shares at $102.50 42% of stake
    Traded Jul 14 Filed Jul 16
  2. Richard E Buller Director
    Planned sale
    $1.3M 9,000 shares at $140.46 57% of stake
    Traded May 4 Filed May 6
  3. David Dalvey Director
    Planned sale
    $3.5M 25,000 shares at $140.68 28% of stake
    Traded May 4 Filed May 6
  4. Richard E Buller Director
    Planned sale
    $331K 3,000 shares at $110.27 31% of stake
    Traded Mar 31 Filed Apr 2
  5. David Dalvey Director
    Planned sale
    $2.4M 20,000 shares at $120.03 18% of stake
    Traded Jan 27 Filed Jan 29
  6. Richard E Buller Director
    Sale
    $317K 3,000 shares at $105.69 31% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
  7. Richard E Buller Director
    Sale
    $108K 1,100 shares at $98.13 13% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
  8. David Dalvey Director
    Planned sale
    $1.5M 15,000 shares at $100.00 12% of stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
  9. Richard E Buller Director
    Sale
    $377K 3,900 shares at $96.73 35% of stake
    Traded Nov 20, 2025 Filed Nov 21, 2025

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants, 8 option exercises, and 6 gifts.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
8-K 7.01,8.01,9.01
8-K 7.01,8.01,9.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13D/A —
SCHEDULE 13G —
8-K 7.01,8.01,9.01
8-K/A 7.01,8.01,9.01
8-K 1.01,1.02,2.03,8.01,9.01
424B5
424B5
8-K 7.01,8.01,9.01
8-K/A 5.02
8-K 5.02,5.07,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
DEFA14A

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$63.78M -$111.78M -$177.04M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $190.59M $244.57M $465.66M
Total non-current assets * $628,801 $552,017 $899,000
Total assets $191.22M $245.12M $466.56M
Total current liabilities $14.19M $31.72M $44.15M
Total non-current liabilities * $37.26M $97.78M $321.85M
Total equity $139.77M $115.62M $100.56M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$53.81M -$83.47M -$153.28M
Cash from investing -$5.01M -$63.07M -$64.08M
Cash from financing $64.91M $138.39M $360.55M
Net change in cash * $6.09M -$8.15M $143.19M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.